12:00 AM
Jun 18, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Activating transcription factor 4 (ATF4); heme oxygenase decycling 1 (HMOX1; HO-1; Hsp32)



Cell culture, mouse and patient sample studies suggest inhibiting ATF4 could help treat cancer. In patients with breast or sarcomal tumors, levels of ATF4 and the antioxidant protein HMOX1 were higher in metastatic...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >